arrow
D

D. Gareth Evans

Ghent University
H指数:182
被引数:13.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RNA splicing evidence enables robust classification of BRCA1 exon 18 variants: Results from the ENIGMA consortium

RNA剪接证据能够实现BRCA1外显子18变异的稳健分类:ENIGMA联盟的研究结果

2026-09-010
PRE
Health-related quality of life after risk-reducing hysterectomy: a randomised vignette study

风险降低性子宫切除术后的健康相关生活质量:一项随机案例研究

2026-08-080
OAAI
Natural menopause, menarche and breast cancer risk in BRCA1 and BRCA2 pathogenic variant carriers: a Mendelian randomization analysis

自然绝经、月经初潮和乳腺癌风险在BRCA1和BRCA2致病性变异携带者中的研究:一项孟德尔随机化分析

2026-03-300
OAAI
Risk of ovarian cancer in women with a pathogenic or likely pathogenic variant in NBN: a systematic review and meta-analysis

携带NBN基因致病性或可能致病性变异的女性罹患卵巢癌的风险:一项系统评价和荟萃分析

2026-02-160
OAAI
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Anti-progestin therapy targets hallmarks of breast cancer risk

抗孕激素疗法靶向乳腺癌风险的标志性特征

Nature
IF48.5
2025-11-050
OAAI
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women

基于家族史、多基因风险评分和传统风险模型的乳腺癌高风险分类阈值重叠:一项针对180,398名女性的研究

2025-11-030
OAAI
Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer

大规模元分析和精确功能测定识别出FANCM区域,其中致病性体细胞突变(PTVs)对ER阴性和三阴性乳腺癌产生不同的风险。

2025-10-300
OAAI
A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated Expert Panel recommendations improve classification of TP53 germline variants for Li-Fraumeni syndrome

一种基于贝叶斯定量分析的基因特异性变异分类方法:更新的专家小组建议改进了TP53生殖细胞变异在Li-Fraumeni综合征中的分类

2025-10-240
OAAI